Niemierko, Andrzej

Proton‐based radiotherapy for unresectable or incompletely resected osteosarcoma

Ciernik, I. F., Niemierko, A., Harmon, D. C., Kobayashi, W., Chen, Y., Yock, T. I., Ebb, D. H., Choy, E., Raskin, K. A., Liebsch, N., et al. (2011) · Cancer

Sarcoma Diagnosis and TreatmentRadiation Therapy and Dosimetry

Cited by 191

Outcomes of proton therapy for patients with functional pituitary adenomas

Wattson, D. A., Tanguturi, S. K., Spiegel, D. Y., Niemierko, A., Biller, B. M. K., Nachtigall, L. B., Bussière, M. R., Swearingen, B., Chapman, P. H., Loeffler, J. S., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics

Pituitary Gland Disorders and TreatmentsRadiation Therapy and Dosimetry

Cited by 125

Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastases

Mak, K. S., Gainor, J. F., Niemierko, A., Oh, K. S., Willers, H., Choi, N. C., Loeffler, J. S., Sequist, L. V., Shaw, A. T., & Shih, H. A. (2015) · Neuro-Oncology

Lung Cancer Treatments and MutationsBrain Metastases and Treatment

Cited by 83

Racial and ethnic disparities in a real-world precision oncology data registry

Cheung, A. T. M., Palapattu, E. L., Pompa, I. R., Aldrighetti, C. M., Niemierko, A., Willers, H., Huang, F., Vapiwala, N., Van Allen, E., & Kamran, S. C. (2023) · npj Precision Oncology

Cancer Genomics and DiagnosticsRace, Genetics, and Society

Cited by 39

First-Generation and Low-Income Students in the National Medical Student Body

Kamran, S. C., Pompa, I. R., Nguyen, H. B., Cha, J., Salinas, K. E., Niemierko, A., & Vapiwala, N. (2025) · JAMA Network Open

Diversity and Career in MedicineHigher Education Research Studies

Cited by 10